HeyPsych
Find SupportPractice ArchitectBrowseSearch

If you're in crisis, help is available 24/7

Call or text 988|More resources
HeyPsych

Better mental health starts with better decisions.

Learn about our clinical review process

Explore

  • Conditions
  • Treatments
  • Tools
  • Find Care

Resources

  • Learn
  • Assessments
  • Support & Crisis
  • For Clinicians

Company

  • About
  • Privacy
  • Terms
  • Contact

© 2026 HeyPsych. All rights reserved.

HeyPsych provides decision-support information. Not a substitute for professional medical advice.

Naltrexone (Vivitrol, ReVia)

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published September 16, 2026•Updated September 16, 2026

Clinical summary for Naltrexone (Vivitrol, ReVia): Naltrexone is a non-addictive medication used in addiction treatment. It can reduce alcohol cravings and helps prevent opioid relapse by blocking opioid receptors. You MUST be opioid-free before starting or it can trigger sudden withdrawal. Don’t test the “block” with opioids—overdose risk goes up, especially near the end of the monthly injection or after stopping.

What It's Used For

Naltrexone is used in addiction psychiatry for alcohol use disorder and opioid use disorder. It’s not a benzo, not a sedative, and it’s not habit-forming. Think of it as a “reward blocker” (alcohol) and a “receptor shield” (opioids).

Primary Indications

Alcohol Use Disorder (moderate to severe): Helps reduce cravings and heavy drinkingOpioid Use Disorder: Prevents opioid effects and helps reduce relapse risk after detoxRelapse prevention: A protective layer when the plan is long-term recovery plus therapy/support

Off-Label Uses

Methamphetamine use disorder (typically as part of combination treatment in specialty care)

What People Feel

People don’t usually describe naltrexone as a “feeling” medication. It’s more like: you notice what doesn’t happen.

Alcohol feels less rewarding

"I could drink, but it just didn’t hit the same."

How Fast It Works

Naltrexone starts blocking receptors quickly, but the real-life benefit (cravings and behavior) can take time to show up consistently.

Oral

~30 to 60 minutes to reach peak levels and start meaningful receptor blockade

Oral

blockade duration is dose-dependent (50 mg is often described as ~24 hours of blockade coverage)

IM (Vivitrol)

starts with an early peak around ~2 hours, then a second peak ~2 to 3 days later

IM

designed for coverage for about 4 weeks (monthly dosing)

If you stop it

overdose risk can rise because tolerance drops and sensitivity can rebound

How Well It Works

Reduced risk of returning to heavy drinking (oral naltrexone 50 mg/day)

NNT ≈ 11
vs Placebo
Across clinical trials, oral naltrexone shows a modest but meaningful benefit in alcohol use disorder, especially for reducing heavy-drinking relapse. The biggest “feel it in real life” wins are fewer binges, less compulsive drinking, and more ability to pause and choose.

Critical Safety Information

Critical Safety Information

If opioids are in your system, naltrexone can trigger sudden withdrawal. And if you try to override the opioid block, you can overdose and die.
  • →Do not take any opioids while on naltrexone. This includes pain pills, some cough meds, and ‘just one’ from someone else’s stash.
  • →Do not “test the block.” Trying to override naltrexone with large opioid doses is a recipe for overdose.
  • →Tell every clinician you see that you’re on naltrexone—especially before surgery or dental work.
  • →If you need planned surgery with possible opioid pain meds: oral naltrexone is typically stopped at least 72 hours beforehand; the IM shot requires planning about a month ahead.
  • →Call your prescriber if you develop severe abdominal pain, dark urine, yellow eyes/skin, or unusually bad fatigue—those can be liver warning signs.
  • →If you feel depressed, hopeless, or suicidal, treat that like an emergency—reach out immediately.

Side Effects

Common issues are nausea, headache, dizziness, insomnia/sleep disturbance, and injection-site reactions with Vivitrol. Most side effects are worst early and improve over time.

Common Things People Notice

  • Nausea (very common, especially early)
  • Headache
  • Dizziness
  • Sleep disruption (insomnia or weird sleep)
  • Anxiety or restlessness
  • Injection-site pain, swelling, lumps, itching (IM formulation)
  • Liver enzyme elevations (usually mild, sometimes serious)

Common Side Effects

Up to ~33% (reported with IM formulation in labeling)
Nausea— This is the classic early side effect. Taking oral naltrexone with food can help. It often fades after the first couple of weeks.
Up to ~25%
Headache— Annoying but usually manageable. If it’s severe or persistent, your prescriber should reassess dosing and other causes.
Up to ~14%
Insomnia / Sleep disturbance— Some people feel wired or sleep gets choppy at first. If sleep is already fragile, plan for this and tighten sleep hygiene early.
About ~12%
Anxiety / Restlessness— This isn’t a calming medication. If anxiety spikes, it may be withdrawal-related (from substances), stress-related, or a medication side effect—don’t guess, evaluate.
Very common (reported as high frequency in labeling; includes nodules, swelling, induration, tenderness, pain, pruritus)
Injection-site reactions (IM)— Expect soreness and a lump sometimes. Severe redness, worsening pain, drainage, fever, or skin breakdown is not normal—get evaluated fast.
Variable; increases are reported (often mild and transient)
Elevated liver enzymes— This is why baseline and periodic liver tests matter—especially if you have hepatitis C, HIV, heavy alcohol use, or are taking other liver-stressing meds.

⚠️ Serious Side Effects

  • Naltrexone-precipitated opioid withdrawal: rapid onset (minutes), severe symptoms, sometimes requiring hospitalization.
  • Accidental opioid overdose: especially after stopping, missing doses, near the end of the injection interval, or attempting to override blockade.
  • Hepatitis / severe liver injury: marked enzyme elevation, jaundice, systemic symptoms.
  • Severe injection-site reactions: abscess, cellulitis, hematoma, tissue necrosis; rare Nicolau syndrome.
  • Depression, suicidal thoughts, suicide attempts (postmarketing reports): requires close monitoring and urgent intervention when present.
  • Seizure (rare, reported): evaluate for other causes and substance-related factors.

Critical Drug Interactions

The main interaction story is simple: opioids and naltrexone do not mix. Beyond that, watch the liver and be smart about combination regimens.

With: Opioids (including partial agonists and opioid-containing products)

Risk: Blocks opioid effects and can precipitate severe withdrawal if opioids are in the body. Attempts to override blockade increase overdose and death risk.

Action: AVOID opioids while on naltrexone. Verify opioid-free status before starting. Make a pain plan before surgery or dental work.

With: Planned or emergency opioid pain management

Risk: Opioids may be ineffective; high-dose attempts can be dangerous. Pain control becomes complicated.

Action: Use non-opioid strategies when possible (regional anesthesia, non-opioid analgesics, general anesthesia strategies). If opioids are required, care should be under trained anesthesia/acute pain specialists.

With: Other hepatotoxic agents (including heavy alcohol use and frequent NSAID use)

Risk: Higher risk of liver enzyme elevation or hepatitis when the liver is already stressed.

Action: Check baseline liver tests and monitor periodically. Reassess if symptoms of liver injury appear.

With: Bupropion (when used in combination approaches for stimulant use disorder)

Risk: Combination can be activating for some patients (anxiety/insomnia). Bupropion also carries seizure risk in vulnerable patients.

Action: If using combination therapy, monitor sleep, anxiety, blood pressure, and seizure risk factors. Adjust timing and dosing to reduce activation.

Safe Discontinuation

Naltrexone does not require a taper. But stopping it is not “no big deal” in addiction care—because relapse and overdose risk can change after discontinuation.

Key Points

  • No taper needed: You can stop oral or IM naltrexone without tapering.
  • Overdose risk warning: After stopping, opioid tolerance can be lower than you remember. Using “your old dose” can kill you.
  • High-risk windows: missed doses, near the end of the monthly injection interval, and the weeks after discontinuation.
  • If relapse happens: treat it as data, not moral failure—re-engage care fast and reassess the treatment plan.
  • Naloxone planning: Patients with opioid use disorder (and their close contacts) should have access to naloxone or nalmefene and know how to use it.

Dosing Information

Adult Dosing

aud oral initial: 25 mg PO once daily for several days (optional expert strategy) before increasing

aud oral typical: 50 mg PO once daily

aud oral max: 100 mg PO once daily after at least 3 days based on response and tolerability

aud im: 380 mg IM (deep gluteal) once every 4 weeks

oud oral induction: 25 mg PO once daily for 1 to 3 days; if no withdrawal signs occur, then 50 mg PO once daily thereafter (medically supervised initiation recommended)

oud im: 380 mg IM (deep gluteal) once every 4 weeks; if clinically wearing off before 4 weeks, some clinicians consider every 3 weeks (limited trial data for <4-week intervals)

methamphetamine use disorder off label: 380 mg IM every 3 to 4 weeks when used as part of combination treatment (commonly paired with bupropion) in specialty addiction care

opioid free requirement: Must be opioid-free (including tramadol) at least 7 to 10 days before starting; up to 14 days may be needed after long-acting opioids (e.g., methadone, buprenorphine). A naloxone challenge may be used when opioid-free status is uncertain.

perioperative discontinuation: If opioid pain management is anticipated: stop oral naltrexone at least 72 hours (3 days) before elective surgery; plan at least 30 days after the last IM injection (oral may be used temporarily if clinically appropriate).

Simple Explanation

Oral naltrexone is a daily pill that works best with strong routines or observed dosing when adherence is hard. Vivitrol is a monthly deep-IM injection that removes the daily decision but requires correct injection technique and long-range planning for surgeries or opioid pain needs.

Pregnancy, Breastfeeding, Special Groups

Naltrexone can be used in select situations, but pregnancy and breastfeeding require careful risk-benefit decisions. For opioid use disorder in pregnancy, naltrexone is generally not the preferred first-line option.

👶Pregnancy

Naltrexone crosses the placenta. Data in pregnancy are limited. It is not typically the preferred medication for opioid use disorder during pregnancy, and extended-release IM naltrexone is generally avoided in pregnant patients in many guideline-based approaches. If a patient is stable on naltrexone and becomes pregnant, the decision to continue vs transition should be individualized based on relapse risk and patient preference, with shared decision-making and close monitoring. Pregnancy testing is commonly recommended before initiation.

🤱Breastfeeding

Naltrexone and its metabolite can be present in breast milk. The decision to breastfeed during therapy should weigh infant exposure risk, benefits of breastfeeding, and benefits of maternal treatment. For alcohol use disorder in breastfeeding patients, pharmacotherapy is generally used cautiously and typically not for routine management unless clearly needed (e.g., severe relapse risk), and non-pharmacologic supports are emphasized.

👧Children & Adolescents (Under 18)

Not applicable for this medication.

👴Older Adults (65+)

Refer to adult dosing. Older adults may have higher medical comorbidity burdens; monitor liver function, dizziness/syncope risk, and medication interactions closely.

🔬Liver Impairment

Do not start during acute hepatitis or acute hepatic failure. In stable cirrhosis, some evidence-based guidance suggests no formal dose adjustment is required for oral or IM dosing, but clinical monitoring is critical. IM naltrexone avoids first-pass metabolism and may have more predictable exposure in liver impairment. If acute worsening of liver function occurs (e.g., hospitalization-level injury), consider interrupting therapy and resume only after resolution and reassessment.

💧Kidney Impairment

Mild impairment: no adjustment typically needed. Moderate-to-severe impairment: use caution (limited study data); naltrexone and metabolite are primarily excreted in urine.

Clinical Monitoring

  • Liver function tests: baseline and periodic (especially in higher-risk patients: hepatitis C, HIV, ongoing heavy alcohol use, older age, higher oral doses, or other hepatotoxic meds).
  • Opioid-free status before initiation (OUD): verify opioid-free interval; consider naloxone challenge when there is doubt. Monitor closely during induction for precipitated withdrawal symptoms.
  • Mood monitoring: depression, irritability, suicidal thoughts—especially early in treatment or with comorbid mood disorders.
  • Injection-site checks (IM): pain, swelling, nodules are common; monitor for severe or worsening reactions (cellulitis, abscess, necrosis).
  • Overdose risk education: revisit at every visit—especially near end of injection interval, after missed doses, and if discontinuing treatment.
  • Pregnancy testing: baseline when clinically relevant and aligned with patient goals and guidelines in addiction care.
  • Infectious disease screening (commonly recommended in OUD care): hepatitis and HIV testing prior to initiation or early in treatment when not already known.
  • Adherence and engagement: oral naltrexone effectiveness collapses when adherence collapses—build a plan (routines, observed dosing, contingency management, supports).

Available Formulations

  • Oral tablets: 50 mg (commonly as naltrexone HCl; generics available)
  • IM extended-release injectable suspension (Vivitrol): 380 mg given once every 4 weeks (single-dose kit; deep IM gluteal only)

Mechanism of Action

Naltrexone is a competitive opioid receptor antagonist with the highest affinity for mu receptors. In opioid use disorder, it blocks the effects of opioids at the receptor level. In alcohol use disorder, blocking endogenous opioid signaling appears to reduce alcohol’s reinforcing “reward” effects and may also influence stress and craving pathways (including hypothalamic-pituitary-adrenal axis effects).

Place in Treatment Algorithm

For alcohol use disorder, naltrexone is a front-line medication option alongside therapy and behavior change support. For opioid use disorder, it’s an alternative to agonist treatments (buprenorphine or methadone) and is best suited for patients who can fully detox first and want a non-agonist approach. It can be a great fit when adherence is strong, the person is motivated, and there’s a solid plan for relapse risk and emergency overdose response.

Frequently Asked Questions

What is naltrexone used for?

In psychiatry/addiction care, naltrexone is used for alcohol use disorder (to reduce cravings and heavy drinking) and opioid use disorder (to block opioid effects and reduce relapse risk after detox). It’s not a sedative and it’s not addictive.

Can I start naltrexone if I’m still drinking?

Yes, many clinicians start it while someone is still drinking. You don’t have to be abstinent first for alcohol use disorder. The bigger issue is making sure you’re not using opioids—because opioids plus naltrexone can trigger sudden withdrawal.

How long do I need to be opioid-free before starting?

Typically at least 7 to 10 days opioid-free (including tramadol). If you were on long-acting opioids like methadone or buprenorphine, some people need up to 14 days. When there’s any doubt, a supervised start and/or naloxone challenge can help confirm you’re truly opioid-free.

What happens if I take opioids while on naltrexone?

You may feel little to nothing because the receptors are blocked. The dangerous part is people trying to override the block by taking larger doses—that can cause overdose and death, especially as the medication wears off or after stopping when tolerance is lower.

Is Vivitrol stronger than oral naltrexone?

It’s not really about “stronger.” Vivitrol is long-acting and removes the daily pill decision, which can be a huge advantage. Oral naltrexone works well when adherence is strong. The best choice is usually the one you can realistically stick with.

What are the most common side effects?

Nausea is the classic one, especially early. Headache, dizziness, sleep problems, and anxiety/restlessness can happen too. With Vivitrol, injection-site reactions are common—anything severe, worsening, or associated with fever, drainage, or skin breakdown needs urgent evaluation.

Does naltrexone affect mood?

It can. Depression and suicidal thoughts have been reported, including postmarketing reports. If mood gets darker, you feel hopeless, or you have suicidal thoughts, treat it like a real emergency and reach out immediately.

Is naltrexone hard on the liver?

It can raise liver enzymes, usually mildly and sometimes transiently. Rarely, more serious hepatitis-type injury has been reported. That’s why baseline and periodic liver tests are standard, and why clinicians avoid starting it during acute hepatitis or liver failure.

What if I need surgery or strong pain medication?

Plan ahead. If opioid pain meds might be needed, oral naltrexone is typically stopped at least 72 hours before elective surgery. With Vivitrol, you generally need about 30 days after the last injection for opioid responsiveness to return. Always tell surgeons, dentists, and ER clinicians you’re on naltrexone.

Do I need to taper off naltrexone?

No taper is required. But stopping changes your risk profile—especially in opioid use disorder—because tolerance drops and overdose risk can rise if relapse occurs. If you stop, you should also have a clear relapse prevention plan and naloxone access if opioids are part of your history.

Can naltrexone be used for methamphetamine use disorder?

Sometimes off-label, usually as part of combination treatment in specialty addiction care (often paired with bupropion). It’s not a guaranteed fix, but it may provide modest benefit for some people when combined with therapy and structured support.

This treatment information is for educational purposes only. Treatment decisions should be made in consultation with qualified healthcare professionals based on individual circumstances, symptoms, and medical history. Do not attempt treatment without professional guidance.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists